Race Oncology Ltd has released a press release.
December 2025 Quarterly Activity Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Racura Oncology
- Racura Oncology Emory University Collaboration
- Racura Oncology Appoints BDD for HARNESS-1 Trial
- Race Oncology Completes $3.22m Private Placement
- Race Receives $2.8m RD Tax Refund
- HARNESS1 Lung Cancer Trial Receives Human Ethics Approval
Later from Racura Oncology
- Racura Develops Novel Cardioprotection Blood Test
- Appendix 4D & Half-Year Financial Statements
- Racura HARNESS-1 Trial Receives Governance Approval
- First Patient Dosed Safely with RC220 in Hong Kong
- First Patient Recruited to HARNESS-1 Lung Cancer Trial
Follow Racura Oncology into a list and get an email when it puts out news.
Follow Racura Oncology